In addition, EVs from tumor cells such as melanoma, breast and lung cancer have been reported to carry the immunosuppressive molecule PD-L1, which promotes tumor growth by misfiring T cells through the binding of the PD-L1 structural domain to PD-1 [102]. This evidence concerns the gene CD274 and melanoma.